HOME >> MEDICINE >> NEWS
Drug reverses bone loss in men with prostate cancer during the first year of treatment

e and can recover bone density that already has been lost," Ryan said.

Researchers also found a positive effect of zoledronic acid on bone markers, measurements of bone loss that are found in blood and urine. This study supports current guidelines that recommend monitoring bone density of men on hormone therapy and initiating bisphosphonate treatment if the bone density falls.

Prostate cancer is the most common cancer in men and the second leading cause of cancer-related death in American men. Overall, 1 in 6 men will develop prostate cancer during his lifetime.


'"/>

Contact: Rachel MacKnight
macknigh@ohsu.edu
503 494-8231
Oregon Health & Science University
25-Feb-2006


Page: 1 2

Related medicine news :

1. Scripps research team reverses Friedreichs ataxia defect in cell culture
2. Exercise reverses unhealthy effects of inactivity
3. Dynamic duo: Combination therapy reverses type 1 diabetes
4. Repetition reverses med students stethoscope shortcomings
5. New drug reverses effects of sleep deprivation on brain
6. Heart valve ring reverses damage from congestive heart failure, easing symptoms
7. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
8. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
9. African-American men understimate risk of prostate cancer
10. Treatment for early prostate cancer associated with type of specialist seen
11. Nonhormonal drug reduces hot flashes in men treated for prostate cancer

Post Your Comments:
(Date:3/6/2015)... New York (PRWEB) March 06, 2015 “On ... dazzling days on the grand stage, to the silver screen ... sparkle throughout with precision toe-tapping numbers and their famous eye-high ... Tomczak deliver the rich history of tap dancing in this ... to come out of the United States. , “On ...
(Date:3/6/2015)... Williamsport, PA (PRWEB) March 06, 2015 ... warning of a national shortfall of 90,000 doctors by ... media, Susquehanna Health (SH) is proactively preparing ... development, recruitment and patient access. , Several factors ... population, increasing number of insured under the Affordable Care ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Jvion, ... the release of a Clostridium Difficile (C Diff) ... The C Diff use case is the latest ... span hospital acquired infections, chronic conditions, and individual ... the C Diff solution flags at risk individuals ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Yisrayl Hawkins, ... Abilene, Texas, has released a new publication explaining how ... , The article titled “Microorganisms Do Much ... explaining how tiny microorganisms were created and designed to ... aware of some of the functions of these micro-kingdom, ...
(Date:3/6/2015)... The producers of Health Briefs TV are ... and vicinity. This is a city which is full of ... outdoor activities. It is also a city where healthcare is ... call the city home and provide care from the nearby ... program will be broadcast on CBS KLEW-TV during the month. ...
Breaking Medicine News(10 mins):Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
(Date:3/5/2015)... 5, 2015  AMRI (NASDAQ: AMRI ) ... newly created position of VP of International Sales, effective ... Vice President of Global Sales and Marketing. ... international sales team in an effort to increase worldwide ... segments. Mr. Pettersson will drive strategy for sales and ...
(Date:3/5/2015)... , March 5, 2015 LUNGevity Foundation, ... Food and Drug Administration,s (FDA) approval of Bristol ... and other immunotherapy treatments add another critical new ... the power of a patient,s own immune system ... been approved specifically for patients with squamous cell ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
Cached News: